FundedIQ
Biotechnology

Southern Research: Funding, Investors & Team (Aug 2026)

Southern Research is a non-profit scientific research organization that has been successfully advancing science in the areas of drug discovery, drug development, and environmental health for the past 80 years. Their impressive track record includes the development of seven FDA-approved cancer drugs and their contribution to the creation of a COVID-19 vaccine currently undergoing clinical trials. These remarkable achievements are made possible by the dedicated individuals at Southern Research who consistently drive scientific advancements in all aspects of their work.

southernresearch.org LinkedIn Birmingham, United States 251-500 employees
Biotechnology Life Science Oncology B2B
Total raised
$750k
Rounds
1
Latest
Undisclosed round
Nov 2023

Southern Research has raised $750k across 1 funding round on record, the most recent an undisclosed round of $750k announced in Nov 2023.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Southern Research Company Profile and Key Stats

Total funding raised
$750k
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$750k in Nov 2023
Employees
251-500
reported band
Headquarters
Birmingham, United States

Latest funding round on record: Nov 2023.

Southern Research Funding Rounds

Date
Round
Amount
Undisclosed round
$750k

Southern Research Founders and Leadership Team

Name
Role
Contact
Thomas Martin
Founder

No contact details are on record for this team yet.

Southern Research Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Southern Research's latest round of $750k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Southern Research in Biotechnology and Birmingham

Companies Similar to Southern Research

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Southern Research Funding FAQs

What does Southern Research do?

Southern Research is a non-profit scientific research organization that has been successfully advancing science in the areas of drug discovery, drug development, and environmental health for the past 80 years. Their impressive track record includes the development of seven FDA-approved cancer drugs and their contribution to the creation of a COVID-19 vaccine currently undergoing clinical trials. These remarkable achievements are made possible by the dedicated individuals at Southern Research who consistently drive scientific advancements in all aspects of their work.

How much funding has Southern Research raised?

Southern Research has raised $750k across 1 round on record. The most recent is an undisclosed round of $750k announced in Nov 2023.

When did Southern Research last raise funding?

Southern Research's most recent funding round on record is an undisclosed round of $750k, announced in Nov 2023.

Who founded Southern Research?

FundedIQ lists Thomas Martin (Founder) at Southern Research.

Where is Southern Research headquartered?

Southern Research is based in Birmingham, Alabama, United States.

How many employees does Southern Research have?

Southern Research is in the 251-500 employee band.

How does Southern Research's funding compare to other Biotechnology startups?

Southern Research's latest round of $750k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Southern Research Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Southern Research is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.